Interleukin-1 receptor antagonist beta (IL-1rabeta)
    7.
    发明授权
    Interleukin-1 receptor antagonist beta (IL-1rabeta) 失效
    白细胞介素-1受体拮抗剂β(IL-1rabeta)

    公开(公告)号:US06399573B1

    公开(公告)日:2002-06-04

    申请号:US09494018

    申请日:2000-01-28

    IPC分类号: A61K3800

    摘要: IL-1ra beta polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IL-1ra beta polypeptides and polynucleotides in the design of protocols for the treatment of chronic and acute inflammation, septicemia, arthritis, inflammatory bowel disease, graft vs. host disease, autoimmunity, stroke, cardiac ischemia, acute respiratory disease syndrome (ARDS), psoriasis, restenosis, traumatic brain injury, AIDS, cachexia, allergy, parasite infection, allergic rhinitis, allergic asthma, atopic dermatitis, allergic inflammatory diseases, and delayed hypersensitivity, among others, and diagnostic assays for such conditions.

    摘要翻译: 公开了通过重组技术制备这种多肽的IL-1raβ多肽和多核苷酸和方法。 还公开了在设计用于治疗慢性和急性炎症,败血症,关节炎,炎症性肠病,移植物抗宿主病,自身免疫,中风,心脏缺血,急性呼吸系统的方案中利用IL-1raβ多肽和多核苷酸的方法 疾病综合征(ARDS),牛皮癣,再狭窄,创伤性脑损伤,艾滋病,恶病质,过敏,寄生虫感染,过敏性鼻炎,过敏性哮喘,特应性皮炎,过敏性炎症疾病和迟发性超敏反应等。

    DNA encoding interleukin-1 receptor antagonist (IL-1ra.beta.)
    10.
    发明授权
    DNA encoding interleukin-1 receptor antagonist (IL-1ra.beta.) 失效
    编码白细胞介素-1受体拮抗剂(IL-1ra beta)的DNA

    公开(公告)号:US5863769A

    公开(公告)日:1999-01-26

    申请号:US790032

    申请日:1997-01-28

    CPC分类号: C07K14/54 A61K38/00

    摘要: IL-1ra beta polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IL-1ra beta polypeptides and polynucleotides in the design of protocols for the treatment of chronic and acute inflammation, septicemia, arthritis, inflammatory bowel disease, graft vs. host disease, autoimmunity, stroke, cardiac ischemia, acute respiratory disease syndrome (ARDS), psoriasis, restenosis, traumatic brain injury, AIDS, cachexia., among others, and diagnostic assays for such conditions.

    摘要翻译: 公开了通过重组技术制备这种多肽的IL-1raβ多肽和多核苷酸和方法。 还公开了在设计用于治疗慢性和急性炎症,败血症,关节炎,炎症性肠病,移植物抗宿主病,自身免疫,中风,心脏缺血,急性呼吸系统的方案中利用IL-1raβ多肽和多核苷酸的方法 疾病综合征(ARDS),牛皮癣,再狭窄,创伤性脑损伤,艾滋病,恶病质等,以及这些病症的诊断测定。